Log in Book a Demo

US Pharma & Biotech Pulmonology - PPC Market Share Analysis April 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Pulmonology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Pulmonology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Domain Share of clicks
breztri.com 25.67
dupixenthcp.com 18.49
dupixent.com 18.39
breztrihcp.com 10.84
copdfoundation.org 7.96
tezspire.com 3.54
dukehealth.org 1.76
airsupra.com 1.75
allergyasthmanetwork.org 1.41
chroniclungdiseases.com 1.24
others 8.95

Copyright © Adthena. All rights reserved.

In the PPC landscape, breztri.com leads with 25.67% click share, followed by dupixenthcp.com at 18.49%. “Others” collectively hold 8.95%, showcasing diverse competition.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Pulmonology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Date breztri.com tezspire.com dupixenthcp.com breztrihcp.com tezspirehcp.com dupixent.com resphealth.org copdfoundation.org airsupra.com dukehealth.org
2025/04/01 0% 1.13% 50.05% 0% 0.32% 31.7% 0% 13.76% 0.88% 0.54%
2025/04/02 0% 0.61% 0% 0% 1% 41.41% 54.44% 0% 1.25% 0.03%
2025/04/03 0% 38.14% 0.61% 0% 18.36% 0% 0% 0% 26.78% 1.27%
2025/04/04 33.47% 0.27% 0% 0.73% 0.41% 30.12% 0% 13.79% 1.14% 0.01%
2025/04/05 19.85% 16.29% 3.95% 14.29% 2.18% 8.91% 0% 0% 5.74% 0.75%
2025/04/06 1.47% 0.33% 22.07% 0.85% 1.26% 1.13% 0% 67.68% 1.59% 0.01%
2025/04/07 34.87% 2.05% 0.4% 19.91% 0.88% 33.88% 0% 0% 0.87% 0.18%
2025/04/08 37.64% 2.89% 1% 11.48% 1.28% 33.95% 0% 0% 0.89% 0.01%
2025/04/09 62.4% 0.16% 3.38% 7.87% 0% 11.12% 0% 0% 6.45% 0.02%
2025/04/10 7.99% 17.85% 2.77% 8.39% 7.04% 7.72% 0% 0.57% 7.34% 0.96%
2025/04/11 4.62% 8.52% 35.08% 2.22% 3.53% 6.19% 0% 25.97% 3.85% 0.31%
2025/04/12 18.33% 5.35% 14.48% 7.33% 4.23% 14% 0% 0% 0.77% 1.01%
2025/04/13 29.83% 0.6% 39.12% 1.15% 0.09% 26.78% 0% 0% 0.6% 0%
2025/04/14 34.07% 0.77% 15.47% 10.22% 0.59% 25.15% 0% 0% 3.34% 0%
2025/04/15 6.26% 9.8% 8.58% 1.6% 6.56% 12.94% 0% 0% 11.65% 0%
2025/04/16 43.48% 2.19% 38.82% 12.27% 0.14% 0.01% 0% 0% 2.15% 0%
2025/04/17 40.12% 2.54% 4.93% 20.89% 0.63% 0.72% 0% 0% 2.53% 17.82%
2025/04/18 33.72% 5.63% 22.65% 18.26% 0.28% 7.38% 0% 0% 0.64% 0.03%
2025/04/19 6.76% 45.63% 0.19% 1.38% 0.12% 37.65% 0% 0% 0.2% 0.37%
2025/04/20 13.89% 17.42% 8.38% 7.98% 11.18% 13.87% 0% 0% 6.76% 0%
2025/04/21 15.63% 41.14% 1.01% 5.43% 3.41% 4.42% 0% 0% 0.01% 0%
2025/04/22 14.87% 19.83% 2.54% 15.57% 9.51% 7.08% 0% 0% 5.3% 0%
2025/04/23 11.18% 23.8% 8.93% 4.5% 14.2% 9.1% 0% 0% 9.5% 0%
2025/04/24 8.89% 15.58% 17.15% 4.56% 5.04% 29.12% 0% 0% 0.64% 0%
2025/04/25 16.66% 10.29% 17.53% 11.08% 11.23% 16.64% 0% 0% 0.52% 0%
2025/04/26 6.35% 9.21% 25.35% 5.19% 0% 9.19% 0% 0% 0.75% 0.91%
2025/04/27 17.05% 3.29% 16.4% 20.42% 0% 1.73% 0% 0% 1.53% 0%
2025/04/28 5.93% 15.34% 0% 5.93% 9.76% 22.04% 0% 0% 0.04% 0%
2025/04/29 12% 13.34% 24.61% 7.09% 7.54% 3.22% 0% 0% 1.44% 0%
2025/04/30 23.58% 16.84% 16.66% 16% 10.02% 8.66% 0% 0% 0% 0%

Copyright © Adthena. All rights reserved.

In April 2025, the PPC landscape for pulmonology saw dynamic shifts. Breztri.com experienced fluctuating spend shares, peaking mid-month. Tezspire.com and Dupixenthcp.com showed consistent activity, while Resphealth.org led early. The month concluded with diverse spend patterns across domains.

Market Exposure

Competitor Count for US Pharma & Biotech Pulmonology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Date Competitor Count
2025/04/01 26
2025/04/02 24
2025/04/03 22
2025/04/04 36
2025/04/05 38
2025/04/06 42
2025/04/07 38
2025/04/08 37
2025/04/09 30
2025/04/10 31
2025/04/11 32
2025/04/12 31
2025/04/13 29
2025/04/14 27
2025/04/15 31
2025/04/16 27
2025/04/17 37
2025/04/18 36
2025/04/19 34
2025/04/20 31
2025/04/21 33
2025/04/22 30
2025/04/23 31
2025/04/24 28
2025/04/25 26
2025/04/26 26
2025/04/27 22
2025/04/28 21
2025/04/29 17
2025/04/30 19

Copyright © Adthena. All rights reserved.

April began with 26 advertisers, peaking at 42 by the 6th. A decline followed, ending the month with 19.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Pulmonology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Name Market Trend
breztrihcp.com 11.48%
tezspire.com 5.62%
dukehealth.org 4.87%
breztri.com 3.48%
zoryve.com 1.23%
airsupra.com -1.11%
chroniclungdiseases.com -2.19%
dupixenthcp.com -2.87%
copdfoundation.org -11.69%
dupixent.com -12.8%

Copyright © Adthena. All rights reserved.

Tezspire.com and breztrihcp.com surged in click share, while dupixent.com and copdfoundation.org faced declines.

Campaign Efficiency

US Pharma & Biotech Pulmonology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date tezspire.com breztri.com dupixenthcp.com tezspirehcp.com breztrihcp.com dupixent.com airsuprahcp.com copdfoundation.org allergyasthmanetwork.org airsupra.com
2025/04/01 0.78% 0% 47.48% 0.28% 0% 31.79% 0% 15.83% 0% 0.98%
2025/04/02 0.44% 0% 0% 1.04% 0% 47.51% 0% 0% 0% 1.45%
2025/04/03 29.26% 0% 0.33% 15.37% 0% 0% 0% 0% 0% 32.29%
2025/04/04 0.23% 30.11% 0% 0.33% 0.35% 29.93% 0.04% 14.93% 0% 2.59%
2025/04/05 20.72% 17.66% 2.53% 1.64% 17.03% 2.46% 3% 0% 0% 10.01%
2025/04/06 0.2% 0.63% 22.61% 1.35% 0.45% 0.1% 0.14% 67.42% 0% 3.9%
2025/04/07 1.45% 30.83% 0.13% 0.86% 15.47% 30.45% 1.41% 0% 0% 1.06%
2025/04/08 2.39% 33.21% 0.77% 1.65% 17.35% 33.25% 2.2% 0% 0% 1.01%
2025/04/09 0.17% 65.27% 2.51% 0% 7.21% 4.91% 2.59% 0% 0% 11.28%
2025/04/10 17.43% 6.88% 3.56% 11.4% 6.82% 8.02% 11.22% 0.28% 0% 11.64%
2025/04/11 7.54% 2.97% 33.09% 4.44% 1.93% 4.38% 3.05% 31.57% 0% 5.12%
2025/04/12 7.03% 14.81% 11.11% 5.57% 5.99% 2.15% 5.66% 0% 0% 0.83%
2025/04/13 0.36% 27.37% 40.41% 0.04% 1.03% 27.67% 0.15% 0% 0% 0.89%
2025/04/14 0.58% 26.53% 12.9% 0.65% 13.7% 25.63% 0.01% 0% 12.79% 5.14%
2025/04/15 11.59% 3.87% 2.83% 11.23% 0.9% 2.56% 15.79% 0% 0% 21.88%
2025/04/16 2.64% 37.45% 37.05% 0.11% 19.1% 0% 0.01% 0% 0% 2.84%
2025/04/17 3.17% 43.77% 3.37% 0.8% 19.85% 0.17% 2.58% 0% 0% 3.58%
2025/04/18 3.62% 33.3% 22% 0.36% 16.35% 7.22% 0.96% 0% 7.11% 0.84%
2025/04/19 34.88% 8.51% 0.19% 0.13% 0.99% 47.59% 0.17% 0% 0% 0.25%
2025/04/20 18.56% 10.7% 7.96% 17.15% 8% 10.58% 5.99% 0% 0% 9.83%
2025/04/21 35.49% 12.3% 0.92% 6.38% 4.6% 6.14% 3.24% 0% 0% 0.02%
2025/04/22 21.26% 13.35% 3.02% 13.57% 18.03% 1.26% 7.09% 0% 0% 7.3%
2025/04/23 25.27% 6.02% 7.13% 18.65% 2.75% 8.92% 13.39% 0% 0% 12.92%
2025/04/24 21.81% 7.52% 15.37% 7.76% 3.86% 17.71% 15.55% 0% 0% 0.92%
2025/04/25 19.66% 18.11% 12.39% 19.66% 11% 7.48% 0.14% 0% 0% 0.66%
2025/04/26 13.85% 4.25% 26.01% 0% 2.77% 13.01% 0.19% 0% 0% 1.01%
2025/04/27 5.27% 9.28% 19.01% 0% 18.9% 1.8% 5.54% 0% 0% 2.73%
2025/04/28 12.14% 3.17% 0% 12.14% 2.23% 2.39% 0.17% 0% 0% 0.06%
2025/04/29 14.91% 8.42% 27.78% 13.29% 4.29% 3.32% 12.48% 0% 0% 1.62%
2025/04/30 18.84% 18.28% 18.14% 17.31% 11.6% 9.81% 2.55% 0% 0% 0%

Copyright © Adthena. All rights reserved.

April’s PPC landscape was dynamic. COPD Foundation’s share peaked at 67.42% on April 6, then plummeted. Tezspire’s share fluctuated, ending strong at 18.84%. Breztri and Dupixent saw mid-month highs, while Airsupra remained steady. The month concluded with diverse performances across domains.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Pulmonology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
  1. 1
    What Are The Symptoms Of COPD? - Review The 4 Stages Of... Prescription treatment website

    Find Out How You May Be Able To Reduce Flare-Ups & Breathe Better With This COPD Inhaler.

  2. 2
    COPD Exacerbation Info - Symptoms Of An Exacerbation Prescription treatment website

    Exacerbations Can Present Significant Dangers. Are You Ready To Help Protect Against Them?

  3. 3
    What Is COPD? - COPD Signs And Symptoms https://www.copdfoundation.org

    COPD Is Currently An Incurable Disease, But There Are Things You Can Do To Breathe Better.

  4. 4
    A Non-Steroid COPD Treatment - Help Manage Your COPD Prescription treatment website

    Download Helpful Resources For Having An Effective Conversation With Your Pulmonologist.

  5. 5
    Official HCP Website - COPD Lung Disease Prescription treatment website

    HCPs: Explore How You Can Help Improve Your Patients With COPD— Visit The Site Today.

Copyright © Adthena. All rights reserved.

In the competitive landscape of COPD treatment, Breztri and Dupixent dominate with compelling narratives. Breztri emphasizes symptom management and flare-up reduction, while Dupixent highlights non-steroid options and professional resources. The COPD Foundation provides educational support, underscoring the incurable nature of COPD.

Frequently Asked Questions

Customer Success Stories

the7stars Case study: PPC campaign Optimization

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study
Sage Case study: Brand protection strategy

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

Related reports

US
Pharma & Biotech

US Pharmacology

US
Pharma & Biotech

US Research and Development

UK
Pharma & Biotech

UK Pharmacology

UK
Pharma & Biotech

UK Research and Development